Azaindole derivatives with high affinity for the dopamine D4 receptor: Synthesis, ligand binding studies and comparison of molecular electrostatic potential maps

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 1, 1999, Pages 97-102

  Löber, Stefan ^a   Hübner, Harald ^a   Gmeiner, Peter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 4 CHLOROPHENYLPIPERAZINYLMETHYL PYRAZOLO[1,5 A]PYRIDINE; CLOZAPINE; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; INDOLE DERIVATIVE; UNCLASSIFIED DRUG;

AMINATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATTLE; DOPAMINE RELEASE; DRUG RECEPTOR BINDING; DRUG TOLERABILITY; ELECTRICITY; LIGAND BINDING; NONHUMAN; RECEPTOR AFFINITY; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

DOPAMINE ANTAGONISTS; ELECTROSTATICS; INDOLES; ISOMERISM; KINETICS; MODELS, CHEMICAL; PYRAZOLES; PYRIDINES; PYRROLES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES;

ANIMALIA; BOS TAURUS;

EID: 0032922157     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00692-1     Document Type: Article

References (27)

1. The Dopamine Receptors; Neve, K.A.; Neve, R.L., Ed.; Humana Press: Totowa, New Jersey, 1997.
2. Sibley, D.R.; Monsma, Jr., F.J. TiPS 1992, 13, 61. Sokoloff, P.; Schwartz, J.-C. TiPS 1995,16, 270.
3. Sibley, D.R.; Monsma, Jr., F.J. TiPS 1992, 13, 61. Sokoloff, P.; Schwartz, J.-C. TiPS 1995,16, 270.
4. Van Tol, H.H.M.; Bu Nzow, J.R.; Guan, H.-C., Sunahara, R.K.; Seeman, P., Niznik, H.B.; Civelli, O. Nature 1991, 350, 610.
5. Strange, P.G. TiPS 1994, 15, 317 and references cited therein.
6. For review: Liegeois, J.-F.; Eyrolles, L.; Brahwyler, J.; Delarge, J. Curr. Med. Chem. 1998, 5, 77.
7. For review: Steiner, G.; Bach, A.; Bialojan, S.; Greger, G.; Hege, H.-G.; Höger, T.; Jochims, K.; Munschauer, R.; Neumann, B.; Teschendorf, H.-J.; Traut, M.; Unger, L.; Gross, G. Drugs Fut. 1998, 23, 191
8. For review: Kulagowski, J.J.; Patel, S. Curr. Pharm. Design 1997, 3, 355 and references cited therein.
9. Gmeiner, P.; Mierau, J.; Höfner, G.; Arch. Pharm. (Weinheim) 1992, 325, 57.
10. Gmeiner, P.; Sommer, J.; Mierau, J.; Höfner, G. Bioorg. Med. Chem. Lett. 1993, 3, 1477.
11. Kulagowski, J.J.; Broughton, H.B.; Curtis, N.R.; Mawer, I.M.; Ridgill, M.P.; Baker, R.; Emms, F.; Freedman, S.B.; Marwood, R.; Patel, Sh.; Patel, Sm.; Ragan, C.I.; Leeson, P.D. J. Med. Chem. 1996, 39, 1941.
12. Bristow, L.J.; Kramer, M.S.; Kulagowski, J.; Patel, S.; Ragan, C.I.; Seabrook, G.R. TiPS 1997, 18, 186.
13. Huisgen, R.; Grashey, R.; Krischke, R. Tetrahedron Lett. 1962, 387.
14. Gmeiner, P.; Schünemann, J. Arch. Pharm. (Weinheim) 1988, 321, 517.
15. Gmeiner, P.; Sommer, J. Arch. Pharm. (Weinheim) 1988, 321, 505.
16. Wright, Jr., W.B. J. Org. Chem. 1962, 27, 1042.
17. 4 (326.8): Calc.: C 66.15 H 5.86 N 17.15; Found: C 65.97 H 5.94 N 16.92.
18. Hanson, R.N.; Hariharan, S.; Astik, R. J. Heterocyclic Chem. 1985, 22, 47.
19. Huisgen, R.; Grashey, R.; Krischke, R. Liebigs Ann. Chem. 1977, 506.
20. Tominaga, Y.; Ichihara, Y.; Mori, T.; Kamio, C.; Hosomi, A. J. Heterocyclic. Chem. 1990, 27, 263.
21. Lombardino, J.G. J. Org. Chem. 1965, 30, 2403.
22. Rival, Y.; Grassy, G.; Michel, G. Chem. Pharm. Bull. 1992, 40, 1170.
23. Sokoloff, P.; Andrieux, M.; Besancon, R.; Pilon, C.; Martres, M.-P.; Giros, B.; Schwartz, J.-C. Eur. J. Pharmacol. 1992, 225, 331.
24. Asghari, V.; Sanyal, S.; Buchwaldt, S.; Paterson, A.; Jovanovic, V.; Van Tol, H.H.M. J.Neurochem. 1995, 65, 1157.
25. Ohnmacht, U.; Tränkle, C.; Mohr, K.; Gmeiner, P. Pharmazie, 1998, in press, and references cited therein.
26. Data are the means of two to three experiments performed in triplicate at eight different concentrations.
27. Ab initio calculations and visualizations have been done using the program package PC SPARTAN PLUS (Wavefunction, Inc.).